Delivery Order SPE2DB24D2205-SPE2DB25FDXPC

Award Date 1/29/25
Potential Completion Date 2/20/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Pfizer COVID-19 vaccines in the 2024-2025 timeframe. The contract has a ceiling value of $1,129.80 and is for 0.9 ml dosages under the Emergency Use Authorization (EUA). The contract is for a firm fixed price and does not have any set-aside designations. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.06 firm fixed price contract is for the delivery of Pfizer COVID-19 vaccine doses from 2024 to 2025, with a period of performance ending on November 29, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a $1,129.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pfizer COVID-19 vaccines from 2024 to 2025, with an ultimate completion date of February 18, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,129.80, is for the procurement of Pfizer COVID-19 vaccine doses to support vaccine requirements from 2024 to 2025, with a potential treatment window of 6 months to 4 years. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,525.97 firm-fixed-price contract is for the supply of the Pfizer COVID-19 vaccine under the Emergency Use Authorization (EUA) for the 2023-2024 period, with an ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Pfizer COVID-19 vaccines in 0.9 mL doses for the 2023-2024 period under an Emergency Use Authorization. The contract has a ceiling value of $1,069.25 and a completion date of April 9, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 0.9 ML Pfizer COVID-19 vaccines for the 2023-2024 period under the Emergency Use Authorization (EUA). The contract has a ceiling value of $1,777.70 and is a firm fixed-price contract. The place of performance is Conshohocken, PA. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This is a $1,069.25 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,309,714 units of the Pfizer COVID-19 vaccine (0.9 mL) under an Emergency Use Authorization (EUA) over a period of 6 months to 4 years. The contract is a Firm Fixed Price (FFP) arrangement with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has...
This federal contract award is a delivery order valued at $1,129.80 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 0.9ML doses of the Pfizer COVID-19 vaccine for the 2024-2025 period, under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of January 3, 2025 and is a firm fixed-price arrangement. This delivery order is part...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order, valued at $1,129.80, is for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 time period, with an ultimate completion date of February 18, 2025. The contract is designated as Firm Fixed Price and does not have a set-aside requirement. This delivery order...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDXPC
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Pfizer COVID-19 vaccine doses from 2024-2025 under the Emergency Use Authorization (EUA). The contract has a ceiling value of $3,389.40 and a completion date of February 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which covers a broad range of pharmaceutical products and medical supplies for military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.

Generated 5/4/25, 12:57 AM